Valore202020212022202320242025TTMFlussi di cassa derivanti dalle attività di investimento-825.37 M-784.73 M-630.35 M-771.8 M-771.43 M-654.95 M-631.9 MLiquidità derivante dalle attività di finanziamento-1.85 B-1.08 B-1.12 B-1.17 B-816.94 M-1.37 B-1.21 BLiquidità libera1.98 B1.93 B1.56 B2.06 B2.02 B1.31 B1.49 B
DaVita Inc. Common Stock
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500.